New in­fluenza drug

Pharmacy Daily - - Front Page -

THE US Food and Drug Ad­min­is­tra­tion has ap­proved a new oral an­tivi­ral flu med­i­ca­tion called Xofluza (balox­avir mar­boxil).

The prod­uct was de­vel­oped by Ja­panese firm Shionogi Co and will be mar­keted in the US by Ge­nen­tech, a mem­ber of the Roche Group of com­pa­nies.

Xofluza is in­di­cated for the treat­ment of acute, un­com­pli­cated in­fluenza, or flu, in peo­ple 12 years of age and older.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.